Quarterly report pursuant to Section 13 or 15(d)

Going Concern (Details Narrative)

v3.23.3
Going Concern (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 30, 2023
Feb. 28, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]                      
Cash, cash equivalents, and federal funds sold     $ 457,934           $ 457,934    
Net loss     3,778,272 $ 2,272,082 $ 2,478,175 $ 2,848,717 $ 1,951,734 $ 1,933,099 8,528,529 $ 6,733,550  
Net cash used in operating activities                 5,644,980 $ 4,966,359  
Proceeds from warrant exercises $ 1,600,000 $ 3,600,000                  
Accumulated deficit     $ 126,424,938           $ 126,424,938   $ 117,896,409